- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
APP mouse models for Alzheimer's disease preclinical studies ; volume:36 ; number:17 ; year:2017 ; pages:2473-2487 ; extent:15
The EMBO journal / European Molecular Biology Organization ; 36, Heft 17 (2017), 2473-2487 (gesamt 15)
- Urheber
-
Sasaguri, Hiroki
Nilsson, Per
Hashimoto, Shoko
Nagata, Kenichi
Saito, Takashi
De Strooper, Bart
Hardy, John
Vassar, Robert
Winblad, Bengt
Saido, Takaomi C.
- DOI
-
10.15252/embj.201797397
- URN
-
urn:nbn:de:101:1-2022092906112032587083
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sasaguri, Hiroki
- Nilsson, Per
- Hashimoto, Shoko
- Nagata, Kenichi
- Saito, Takashi
- De Strooper, Bart
- Hardy, John
- Vassar, Robert
- Winblad, Bengt
- Saido, Takaomi C.
Ähnliche Objekte (12)
The App NL-G-F mouse retina is a site for preclinical Alzheimer’s disease diagnosis and research
Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer’s disease
Correction: Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer’s disease
Emergence of synaptic and cognitive impairment in a mature-onset APP mouse model of Alzheimer’s disease
Pridopidine Promotes Synaptogenesis and Reduces Spatial Memory Deficits in the Alzheimer’s Disease APP/PS1 Mouse Model
APOE effects on regional tau in preclinical Alzheimer’s disease
An olfactory ‘stress test’ may detect preclinical Alzheimer’s disease
Inflammatory plasma biomarkers in subjects with preclinical Alzheimer’s disease
Neuroprotective effects of berberine in animal models of Alzheimer’s disease: a systematic review of pre-clinical studies
Protective effect of PDE4B subtype-specific inhibition in an App knock-in mouse model for Alzheimer’s disease
Preclinical Alzheimer’s dementia: a useful concept or another dead end?
Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
The App NL-G-F mouse retina is a site for preclinical Alzheimer’s disease diagnosis and research
Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer’s disease
Correction: Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer’s disease
Emergence of synaptic and cognitive impairment in a mature-onset APP mouse model of Alzheimer’s disease
Pridopidine Promotes Synaptogenesis and Reduces Spatial Memory Deficits in the Alzheimer’s Disease APP/PS1 Mouse Model
APOE effects on regional tau in preclinical Alzheimer’s disease
An olfactory ‘stress test’ may detect preclinical Alzheimer’s disease
Inflammatory plasma biomarkers in subjects with preclinical Alzheimer’s disease
Neuroprotective effects of berberine in animal models of Alzheimer’s disease: a systematic review of pre-clinical studies
Protective effect of PDE4B subtype-specific inhibition in an App knock-in mouse model for Alzheimer’s disease
Preclinical Alzheimer’s dementia: a useful concept or another dead end?
Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
The App NL-G-F mouse retina is a site for preclinical Alzheimer’s disease diagnosis and research
Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer’s disease
Correction: Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer’s disease
Emergence of synaptic and cognitive impairment in a mature-onset APP mouse model of Alzheimer’s disease
Pridopidine Promotes Synaptogenesis and Reduces Spatial Memory Deficits in the Alzheimer’s Disease APP/PS1 Mouse Model
APOE effects on regional tau in preclinical Alzheimer’s disease
An olfactory ‘stress test’ may detect preclinical Alzheimer’s disease
Inflammatory plasma biomarkers in subjects with preclinical Alzheimer’s disease
Neuroprotective effects of berberine in animal models of Alzheimer’s disease: a systematic review of pre-clinical studies
Protective effect of PDE4B subtype-specific inhibition in an App knock-in mouse model for Alzheimer’s disease
Preclinical Alzheimer’s dementia: a useful concept or another dead end?